Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-26 @ 4:18 PM
Study NCT ID:
NCT00902304
Status:
COMPLETED
Last Update Posted:
2012-12-04
First Post:
2009-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
Sponsor:
Novartis Pharmaceuticals
Organization:
Study Overview
Official Title:
A Phase IV Clinical Trial of Intensified Blood Pressure Management in Primary Care Using Valsartan Alone and as Combination Anti-Hypertensive Therapy
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VIPER-BP
Brief Summary:
This study will assess the efficacy of an intensive blood pressure management strategy compared to usual care in a primary care (general practice) setting.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: